7 Patents
- US123446562025Genetically Engineered T Cells Having Improved Persistence in Culture
CRISPR Therapeutics AG
0 cites - 0 cites
- US118575742024Genetically Engineered T Cells with Regnase-1 And/or TGFBRII Disruption Have Improved Functionality and Persistence
CRISPR Therapeutics AG
0 cites - US116791302023Genetically Engineered T Cells with Regnase-1 And/or TGFBRII Disruption Have Improved Functionality and Persistence
CRISPR Therapeutics AG
0 cites - US116791312023Genetically Engineered T Cells with Regnase-1 And/or TGFBRII Disruption Have Improved Functionality and Persistence
CRISPR Therapeutics AG
0 cites - 0 cites
- US116229772023Materials and Methods for Engineering Cells and Uses Thereof in Immuno-oncology
CRISPR THERAPEUTICS AG
0 cites